• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

PharmaDiagnostics

edit

PharmaDiagnostics NV engages in the development of analytical techniques to accelerate the drug discovery process. The company provides human albumin binding, human orosomucoid, membrane, and redox potential assays, as well as assay systems, which include experimental pKa, experimental log D, P-glycoprotein interaction, Cytochromes P450 interactions, and solubility of new chemical entities in fasted and fed intestinal conditions. It offers assays to the pharmaceutical and biotech industries. The company is based in Zellik, Belgium.

Recent Milestones

edit

• 
  PharmaDiagnostics received $3.7M in Series B funding. (1/21/10)
  Posted 1/22/10 at 4:05am via onbiovc.com
• 
  PharmaDiagnostics added Bruno Van Eesbeeck as CEO.
  Posted 1/22/10 at 4:05am
• 
  PharmaDiagnostics added Anne Van Hoonacker as CTO.
  Posted 1/22/10 at 4:05am

Videos

Screenshots

edit

Sources

1. PharmaDiagnostics, NV: Series B $3.7M (onbiovc.com) [edit]